US Bancorp’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

US Bancorp’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,000	Closed	-$420	–	4139
2024 Q1	$420	Hold	3,000	–	–	﹤0.01%	3873
2023 Q4	$436	Hold	3,000	–	–	﹤0.01%	3860
2023 Q3	$525	Hold	3,000	–	–	﹤0.01%	3842
2023 Q2	$9.36K	Hold	3,000	–	–	﹤0.01%	3284
2023 Q1	$7.68K	Hold	3,000	–	–	﹤0.01%	3378
2022 Q4	$4.47K	Sell	3,000 -383	-11%	-$621	﹤0.01%	3550
2022 Q3	$6K	Hold	3,383	–	–	﹤0.01%	3564
2022 Q2	$4K	Buy	3,383 +2,000	+145%	+$3.42K	﹤0.01%	3686
2022 Q1	$3K	Sell	1,383 -9,579	-87%	-$25K	﹤0.01%	3782
2021 Q4	$51K	Buy	10,962 +383	+4%	+$1.27K	﹤0.01%	2652
2021 Q3	$86K	Hold	10,579	–	–	﹤0.01%	2379
2021 Q2	$104K	Buy	+10,579	New	+$86K	﹤0.01%	2288

Other funds holding GRTX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

US Bancorp's GRTX Position: Q2 2024 in Review

US Bancorp sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 3,000 shares — an estimated $420 sold.

US Bancorp first reported a position in GRTX in Q2 2021 and held it in 12 quarters. The position peaked at $104K in Q2 2021. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

US Bancorp reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
US Bancorp sold 3,000 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $420.
US Bancorp first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
US Bancorp's Galera Therapeutics, Inc. Common Stock position peaked at $104K in Q2 2021.
1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on US Bancorp's 13F filing for Q2 2024, filed 7 Aug 2024.